Medicare Proposes Changes To ASP Reporting Requirements For Part B Drugs
CMS is proposing to expand average sales price (ASP) data reporting requirements for manufacturers to include wholesale acquisition costs of Medicare Part B drugs
You may also be interested in...
The Centers for Medicare & Medicaid Services is forging ahead with its proposal to set pharmacy reimbursement levels under Medicaid at average sales price plus 6% for drugs, despite opposition from industry groups and state governors
CMS' definition of "average sales price" for drugs closely follows the language in the Medicare Rx law
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011